A MicroRNA Signature in Pediatric Ulcerative Colitis: Deregulation of the miR-4284/CXCL5 Pathway in the Intestinal Epithelium

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Inflammatory Bowel Diseases

• Publication date

  2015-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/MIB.0000000000000339PMID 25738378PMCID PMC4402238
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetics and Pathogenesis of Inflammatory Bowel Disease.

  2016cited by this paper
• Systems biology in inflammatory bowel diseases: ready for prime time

  2014cited by this paper
• Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.

  2014cited by this paper
• Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon.

  2014cited by this paper
• Tailoring anti-TNF therapy in IBD: drug levels and disease activity

  2014influential reference
• Differences in the management of pediatric and adult onset ulcerative colitis--lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis.

  2014influential reference
• Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis

  2013influential reference
• Recent advances in pediatric gastroenterology, hepatology and nutrition

  2013cited by this paper
• MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.

  2013cited by this paper
• MicroRNA-21 Knockout Improve the Survival Rate in DSS Induced Fatal Colitis through Protecting against Inflammation and Tissue Injury

  2013cited by this paper
• Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes

  2012influential reference
• Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

  2012cited by this paper
• Genetics and pathogenesis of inflammatory bowel disease

  2011cited by this paper
• An HNF4a-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis

  2011cited by this paper
• The Role of MicroRNA in Inflammatory Bowel Disease.

  2010influential reference
• Identification of microRNAs associated with ileal and colonic Crohn's disease†

  2010cited by this paper
• STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.

  2010cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

  2009cited by this paper
• The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs.

  2009cited by this paper
• Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

  2009cited by this paper
• MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.

  2008cited by this paper
• The microRNA.org resource: targets and expression

  2007cited by this paper
• Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice

  2007cited by this paper
• NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

  2006cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis.

  2005cited by this paper
• Rapid development of colitis in NSAID-treated IL-10-deficient mice.

  2002cited by this paper
• Chemokines in the Inflammatory Bowel Diseases

  1999cited by this paper
• Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis.

  1997influential reference
• The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease.

  1997cited by this paper
• Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis.

  1994cited by this paper
• Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8

  1991cited by this paper

• Inhibition of miR-4284 could reduce apoptosis and neuroinflammation by targeting APBA1/JAK1/STAT3 signaling in Alzheimer’s disease

  2025cites this paper
• The role of miR‐4284 in cancer progression and therapeutic response: Regulatory mechanisms and clinical implications

  2025cites this paper
• The importance of ALPK1 kinase functionality as a potential biomarker for inflammatory diseases

  2025cites this paper
• Transcription factor ELF-1 protects against colitis by maintaining intestinal epithelium homeostasis

  2025cites this paper
• Downregulation of miR-4284 can inhibit the apoptosis of Human Arterial Smooth Muscle Cells (HASMCs) in arteriosclerosis obliterans (ASO).

  2023cites this paper
• Peripheral blood mononuclear cells‐expressed miRNA profiles derived from children with metabolic‐associated fatty liver disease and insulin resistance

  2022cites this paper
• Salivary microRNA profiling dysregulation in autism spectrum disorder: A pilot study

  2022cites this paper
• Role of microRNAs in tumor progression among Iranian population: An overview

  2022cites this paper
• Epigenetic regulation of pediatric and neonatal immune responses

  2021cites this paper
• Mucosal microRNAs relate to age and severity of disease in ulcerative colitis

  2021cites this paper
• MicroRNAs in Colon Tissue of Pediatric Ulcerative Pancolitis Patients Allow Detection and Prognostic Stratification

  2021cites this paper
• Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease

  2021cites this paper
• CMAR_A_305379 5865..5872

  2021cites this paper
• The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability

  2021cites this paper
• Role of microRNAs in the Pathophysiology of Ulcerative Colitis

  2021influential citation
• Current diagnostics for chronic enteropathies in dogs.

  2021cites this paper
• MicroRNA expression in inflammatory bowel disease-associated colorectal cancer

  2021cites this paper
• miR-4284 Promotes Cell Proliferation, Migration, and Invasion in Non-Small Cell Lung Cancer Cells and is Associated with Postoperative Prognosis

  2021cites this paper
• The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease.

  2020cites this paper
• The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease

  2020cites this paper
• Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinoma

  2020cites this paper
• Possible role of microRNA miRNA-IL-25 interaction in mice with ulcerative colitis

  2020cites this paper
• microRNA in inflammatory bowel disease at a glance.

  2020cites this paper
• MicroRNAs and Inflammatory Bowel Disease

  2019cites this paper
• Abnormal inhibition of osteoclastogenesis by mesenchymal stem cells through the miR-4284/CXCL5 axis in ankylosing spondylitis

  2019cites this paper
• Detection of IL-10 gene polymorphisms in patients with ulcerative colitis in Northern Iran

  2019cites this paper
• Taraxacum officinale extract ameliorates dextran sodium sulphate‐induced colitis by regulating fatty acid degradation and microbial dysbiosis

  2019cites this paper
• MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease

  2019cites this paper
• Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease.

  2018cites this paper
• MicroRNA-200a Targets Cannabinoid Receptor 1 and Serotonin Transporter to Increase Visceral Hyperalgesia in Diarrhea-predominant Irritable Bowel Syndrome Rats

  2018cites this paper
• Environmental Factors and Their Influence on Intestinal Fibrosis

  2018cites this paper
• A tale of three RNAs in mitochondria: tRNA, tRNA derived fragments and mitomiRs.

  2017cites this paper
• Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility

  2017cites this paper
• Etiopathogenesis of inflammatory bowel disease: today and tomorrow.

  2017cites this paper
• Polymorphisms in MIR122, MIR196A2, and MIR124A Genes are Associated with Clinical Phenotypes in Inflammatory Bowel Diseases

  2017cites this paper
• Rearrangements of 7q11.23: disorders of the epigenome

  2017cites this paper
• Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology.

  2017cites this paper
• Challenges for epigenetic research in inflammatory bowel diseases.

  2017cites this paper
• Interferon-γ alters the immune-related miRNA expression of microvesicles derived from mesenchymal stem cells

  2017cites this paper
• The IBD interactome: an integrated view of aetiology, pathogenesis and therapy

  2017cites this paper
• Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics

  2017cites this paper
• Expression profiling of microRNAs in human bone tissue from postmenopausal women

  2017cites this paper
• Diet and microbiota in inflammatory bowel disease: The gut in disharmony

  2017cites this paper
• MicroRNA-141 Is Involved in Ulcerative Colitis Pathogenesis via Aiming at CXCL5

  2017cites this paper
• Etiopathogenesis of inflammatory bowel disease : today and tomorrow

  2017cites this paper
• Role of MiRNAs in Inflammatory Bowel Disease

  2017cites this paper
• Functional Implications of MicroRNAs in Crohn’s Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling

  2017cites this paper
• Interferon-γ alters the immune-related miRNA expression of microvesicles derived from mesenchymal stem cells

  2017cites this paper
• Targeting microRNAs: a new action mechanism of natural compounds

  2016cites this paper
• Colonic Mucosal Epigenome and Microbiome Development in Children and Adolescents

  2016cites this paper
• A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation.

  2016cites this paper
• Gene expression regulation microRNA-dependent in two different pathological conditions: celiac disease and hypoxia

  2016cites this paper
• Title A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS 1 as an enhancer of inflammation

  2016cites this paper
• A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS 1 as an enhancer of inflammation A long noncoding RNA signature in Ulcerative Colitis

  2016cites this paper
• MicroRNA in Inflammatory Bowel Disease

  2016cites this paper
• MicroRNAs: how many in inflammatory bowel disease?

  2016cites this paper
• Assessment of disease activity in pediatric ulcerative colitis

  2016cites this paper
• Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease

  2016cites this paper
• A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation

  2016cites this paper
• Microbiome–Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases

  2016cites this paper
• Implication des microARNs dans la conversion des adipocytes blancs en adipocytes thermogéniques

  2015cites this paper